1U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement[J].Ann Intern Med,2008,149(3):185-191.
2Schr?derFH,HugossonJ,RoobolMJ, et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up[J].Lancet, 2014, 384(9959):2027-2035.
3PhilipJ,Dutta RoyS,BallalM, et al. Is a digital rectal examination necessary in the diagnosis and clinical staging of early prostate cancer? [J]. BJU Int,2005,95(7):969-971.
4VisAN,BoermaMO,CiattoS,et al. Detection of prostate cancer: a comparative study of the diagnostic efficacy of sextant transrectal versus sextant transperineal biopsy[J]. Urology, 2000,56(4):617-621.
5LiH,YanW,ZhouY, et al. Transperineal ultrasound-guided saturation biopsies using 11-region template of prostate: report of 303 cases[J]. Urology, 2007,70(6):1157-1161.
6Isom-BatzG,BiancoFJ,KattanMW, et al. Testosterone as a predictor of pathological stage in clinically localized prostate cancer[J]. J Urol,2005,173(6):1935-1937.
7DaiB,QuY,KongY, et al. Low pretreatment serum total testosterone is associated with a high incidence of Gleason score 8-10 disease in prostatectomy specimens: data from ethnic Chinese patients with localized prostate cancer[J]. BJU Int, 2012,110(11 Pt B):E667-672.
8WalshPC. Radical prostatectomy with preservation of sexual function impact on cancer control.The controversy[J]. Urol Clin North Am,1987,14(4):663-673.
9MA-AUA,Mid-Atlantic Section of the American Urological Association, 66th Annual Meeting, Cambridge, Maryland, USA, September 25-28, 2008.Can J Urol,2008,15(4):4200-4218.
10YoshiokaY. Current status and perspectives of brachytherapy for prostate cancer[J].Int J Clin Oncol, 2009,14(1):31-36.
